$348.31+16.03% · 3M
Moving avg
1W-1.63%
1M-2.98%
3M+14.99%
6M+39.05%
YTD+26.01%
1Y+41.47%
3Y-12.90%
5Y-21.13%
52-week range
$223.8377% of range$386.00
Company health
Value0/6
Growth3/6
Profitability4/6
Health6/6
Dividend4/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- High return on equity (1851%)
- Net cash on the balance sheet
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$24.51B
Enterprise value
$23.67B
P/E ratio (TTM)
42.79x
P/S ratio (TTM)
7.15x
EV/EBITDA
28.72x
Per share & returns
EPS (TTM)
$7.98
Dividend yield
0.26%
Beta (1Y)
1.16
30-day change
-2.98%
Trading
Volume (24h)
194.96K
Previous close
$352.29
Shares outstanding
70.38M
About West Pharmaceutical Services, Inc.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Exchange
NYSE
Symbol
WST
West Pharmaceutical Services, Inc. is a large-cap healthcare company in the Medical - Instruments & Supplies industry. Its shares are listed on NYSE (United States) and trade under the ticker WST.
Frequently asked questions
What is West Pharmaceutical Services, Inc.'s market cap?
West Pharmaceutical Services, Inc. (WST) has a market capitalization of $24.51B.
What is West Pharmaceutical Services, Inc.'s P/E ratio?
West Pharmaceutical Services, Inc. trades at a price-to-earnings (P/E) ratio of 42.79.
What exchange does WST trade on?
WST trades on NYSE.
Appears in
Eli Lilly and CompanyLLY
$1,220.02-0.02%
$1.15T cap
Johnson & JohnsonJNJ
$261.21+0.13%
$629.49B cap
AbbVie Inc.ABBV
$250.31+0.62%
$442.25B cap
UnitedHealth Group IncorporatedUNH
$403.33-0.56%
$366.28B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$355.30B cap
Merck & Co., Inc.MRK
$134.58+1.25%
$332.39B cap
Novartis AGSWX: NOVN
CHF 123.96-0.19%
$290.28B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.27B cap